Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 More Search Options

Search Results (53)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Bullous pemphigoid associated with nivolumab, a programmed cell death 1 protein inhibitor.Academic Article Why?
Programmed Cell Death 1 ReceptorConcept Why?
Structure and interactions of the human programmed cell death 1 receptor.Academic Article Why?
Mustafa, BahaaPerson Why?
A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.Academic Article Why?
Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.Academic Article Why?
Expression of programmed death-1 on lymphocytes in myeloma patients is lowered during lenalidomide maintenance.Academic Article Why?
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell Carcinoma.Academic Article Why?
Nivolumab reactivation of hypertrophic lichen planus, a case report and review of published literature.Academic Article Why?
Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.Academic Article Why?
VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction.Academic Article Why?
Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.Academic Article Why?
Expression of PD-1 and PD-Ls in Kaposi's sarcoma and regulation by oncogenic herpesvirus lytic reactivation.Academic Article Why?
Expression of PD-1 on peripheral blood Treg cells is related to the diagnosis, prognosis and treatment of T cell non-Hodgkin lymphoma.Academic Article Why?
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.Academic Article Why?
Programmed Cell Death-One Inhibition Therapy in Classical Hodgkin Lymphoma.Academic Article Why?
Al Hadidi, SamerPerson Why?
Qin, ZhiqiangPerson Why?
Indicators of responsiveness to immune checkpoint inhibitors.Academic Article Why?
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.Academic Article Why?
PD-1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B-cell lymphoma.Academic Article Why?
Tackett, AlanPerson Why?
Hsu, Ping-ChingPerson Why?
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?Academic Article Why?
Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.Academic Article Why?
Per Page    Page  of 3last Nextnext
Prev
Search Criteria
  • PD 1 Receptor
Filter by Type